Search for: "Janssen Research " Results 101 - 120 of 199
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jul 2015, 2:51 pm by Dr. Shezad Malik
Johnson & Johnson’s Janssen Pharmaceuticals unit manufactures and distributes Invokana (canagliflozin), for patients with type-2 diabetes, to control their blood-sugar levels. [read post]
10 Jun 2015, 11:51 am by Tom Lamb
  This news report from Medscape, "Four Diabetic Ketoacidosis Episodes Triple Risk of Early Death", provides a summary of and some contextual information about this important new medical study: In a cohort of adult patients with type 1 diabetes who were hospitalized with diabetic ketoacidosis (DKA) in Edinburgh, Scotland, almost all patients survived the hospitalization, but they had an increased risk of early death, new research shows. [read post]
6 Apr 2015, 6:27 pm by Altman & Altman
In other Topamax news, new research indicates that Topiramate (its generic name) can exacerbate or trigger eating disorder symptoms in certain adolescents. [read post]
24 Mar 2015, 11:54 am by Dr. Shezad Malik
Most recently, a wrongful death lawsuit was filed against the makers of Xarelto; Bayer Healthcare and Johnson and Johnson’s subsidiary, Janssen. [read post]
1 Mar 2015, 10:51 am by Dr. Shezad Malik
According to several recent studies there are concerns about those claims, with researchers noting that Xarelto blood tests may help doctors identify patients at the greatest risk of bleeding. [read post]
14 Jan 2015, 4:34 pm by Sabrina I. Pacifici
  While YODA members may reach out to Janssen researchers with questions, the final decision on data sharing will be made by YODA. [read post]
10 Nov 2014, 4:00 am by Howard Friedman
Janssen, Led Blindly: One Circuit's Struggle to Faithfully Apply the U.S. [read post]
18 Oct 2014, 1:09 pm by Dr. Shezad Malik
Researchers found that over half of patients experienced symptoms lasting more than a year, and 80% characterized the nerve problems as severe. [read post]
8 Sep 2014, 12:00 am by David Jensen
Last month, the firm announced it had received $20 million (see here and here) from Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. [read post]
14 May 2014, 11:30 am by D Daniel Sokol
Maarten Janssen (National Research University Higher School of Economics), Alexei Parakhonyak (National Research University Higher School of Economics), and Anastasia Parakhonyak (Toulouse School of Economics) analyze Non-reservation price equilibria and Consumer search. discuss Non-reservation price equilibria and Consumer search. [read post]
28 Feb 2014, 9:27 pm by Legal Reader
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]
27 Feb 2014, 12:46 pm
Researchers followed the pediatric subjects beginning from their first trimester in utero for up to 15 years. [read post]
13 Feb 2014, 11:10 am
  So if some plaintiff tries to TwIqbal your affirmative defenses, you can save yourself considerable research time by checking out this article.A second time saver is a 50-state survey – complete with helpful charts – of the comparative fault/contributory negligence law of every state and the District of Columbia. [read post]
3 Feb 2014, 4:05 am by Howard Friedman
Janssen, Led Blindly: One Circuit's Struggle to Faithfully Apply the U.S. [read post]